China Merchants China Direct Investments Invests RMB 15 Million in Neuracle Technology

China Merchants China Direct Investments Limited announced that its wholly-owned subsidiary, Shenzhen Tian Zheng Investment Co., Ltd., has entered into a share purchase agreement and related agreements dated 28 October 2025 to invest in Neuracle Technology (Shanghai) Co., Ltd. Under the terms of the deal, Tian Zheng agreed to contribute RMB 15 million as part of Neuracle Technology’s Series E funding round. The capital contribution was completed on 7 November 2025. This investment aims to strengthen the company’s portfolio in the medical sector, particularly in innovative brain-computer interface technology. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Merchants China Direct Investments Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251201-11935506), on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)